EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review

Johnathon Gorman, Matteo Candeloro, Sam Schulman iD

Thrombosis and Haemostasis · 01.10.2023 · 123 (10) · 966-975

DOI: 10.1055/a-2068-6464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.10.2023. Verfasst von Johnathon Gorman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Vancouver Stroke Program, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Venous Thromboembolism, Venous Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited data on anticoagulant management of acute venous thromboembolism (VTE) after spontaneous intracranial hemorrhage (ICH).

Methods

We reviewed retrospectively all cases diagnosed with VTE during hospitalization for spontaneous ICH at our center during 15 years. Anticoagulation management outcomes were (1) timing after ICH of anticoagulant initiation for VTE treatment, (2) use of immediate therapeutic dosing or stepwise dose escalation, and (3) the proportion achieving therapeutic dose. Primary clinical effectiveness outcome was recurrent VTE. Primary safety outcome was expanding ICH.

Results

We analyzed 103 cases with VTE after 11 days (median; interquartile range [IQR]: 7–22) from the diagnosis of ICH. Forty patients (39%) achieved therapeutic anticoagulation 21.5 days (median; IQR: 14–34 days) from the ICH. Of those, 14 (35%; 14% of total) received immediately therapeutic dose and 26 (65%; 25% of total) had stepwise escalation. Anticoagulation was more aggressive in patients with VTE >14 days after admission versus those with earlier VTE diagnosis. Twenty-two patients (21%) experienced recurrent/progressive VTE—less frequently among patients with treatment escalation within 7 days or with no escalation than with escalation >7 days from the VTE. There were 19 deaths 6 days (median; IQR: 3.5–15) after the index VTE, with significantly higher in-hospital mortality rate among patients without escalation in anticoagulation.

Conclusion

Prompt therapeutic anticoagulation for acute VTE seems safe when occurring more than 14 days after spontaneous ICH. For VTE occurring earlier, it might also be safe with therapeutic anticoagulation, but stepwise dose escalation to therapeutic within a 7-day period might be preferable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismVenous ThrombosisHumansAnticoagulantsRetrospective StudiesIntracranial Hemorrhages

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Neurology, Vancouver Stroke Program, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton Ontario, Canada.
  • Department of Innovative Technologies in Medicine and Dentistry, "G. D'Annunzio" University, Chieti, Italy.

ORCID-Profile: Sam Schulman

Zitieren

APA

Gorman, J., Candeloro, M., & Schulman, S. (2023). Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review. Thrombosis and Haemostasis, 123(10), 966-975. https://doi.org/10.1055/a-2068-6464

Vancouver

Gorman J, Candeloro M, Schulman S. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review. Thrombosis and Haemostasis. 2023;123(10):966-975. doi:10.1055/a-2068-6464

BibTeX
@article{Gorman2023,
  author = {Gorman, Johnathon and Candeloro, Matteo and Schulman, Sam},
  title = {Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review},
  journal = {Thrombosis and Haemostasis},
  year = {2023},
  volume = {123},
  number = {10},
  pages = {966--975},
  doi = {10.1055/a-2068-6464}
}
Kostenlos starten →